Growth Metrics

Ultragenyx Pharmaceutical (RARE) Cash from Investing Activities (QoQ) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Ultragenyx Pharmaceutical 2.29 Bn 1.89 Bn 106.00 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 32.18%
Dec 31, 2025 -161.65%
Sep 30, 2025 64.89%
Jun 30, 2025 -40.78%
Mar 31, 2025 17.07%
Dec 31, 2024 137.21%
Sep 30, 2024 -554.89%
Jun 30, 2024 -35.87%
Mar 31, 2024 188.24%
Dec 31, 2023 -266.45%
Sep 30, 2023 -35.33%
Jun 30, 2023 -10.68%
Mar 31, 2023 164.86%
Dec 31, 2022 -6.02%
Sep 30, 2022 -304.45%
Jun 30, 2022 311.89%
Mar 31, 2022 -154.10%
Dec 31, 2021 269.43%
Sep 30, 2021 1.18%
Jun 30, 2021 77.39%
Mar 31, 2021 -286.34%
Dec 31, 2020 202.24%
Sep 30, 2020 -11.17%
Jun 30, 2020 9.45%
Mar 31, 2020 -241.42%
Dec 31, 2019 -15.19%
Sep 30, 2019 235.75%
Jun 30, 2019 42.26%
Mar 31, 2019 -237.56%
Dec 31, 2018 353.94%
Sep 30, 2018 131.12%
Jun 30, 2018 26.69%
Mar 31, 2018 -223.76%
Dec 31, 2017 92.66%
Sep 30, 2017 241.33%
Jun 30, 2017 -98.47%
Mar 31, 2017 -48.47%
Dec 31, 2016 -113.62%
Sep 30, 2016 118.92%
Jun 30, 2016 10.15%
Mar 31, 2016 164.88%
Dec 31, 2015 76.65%
Sep 30, 2015 -29.46%
Jun 30, 2015 -2,630.90%
Mar 31, 2015 76.12%
Dec 31, 2014 -25.66%
Sep 30, 2014 50.70%
Jun 30, 2014 57.99%
Mar 31, 2014 -688.48%
Dec 31, 2013 1,512.07%
Sep 30, 2013 98.17%
Jun 30, 2013 -184.50%